Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 2,444 shares at $14.03 ($34K) on 2025-10-24, disclosed to the SEC on 2025-10-28.
Scheduled sale ($34k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.03 | 1,129 | $16K | 46.3% |
| 2 | $13.99 | 1,315 | $18K | 53.7% |
| Total | $14.01 avg | 2,444 | $34K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |